Publications & Resources

MLMIC has released a new edition of The Albany Report to help physicians, dentists and other healthcare providers understand the impact of the most recent Legislative session on their practice in New York State.

The teach-back method can help physicians ensure that patients have a clear understanding of post-visit instructions.

The Spring 2019 edition of Dental Dateline – the newsletter for MLMIC-insured dentists – includes a case study about factors involved in a damaged lingual nerve and tips for responding to unflattering online reviews.

Researchers recently measured physician knowledge about the Americans with Disabilities Act (ADA) and found that doctors lack specific understanding of the issues and barriers patients encounter. Because of these knowledge gaps, physicians may fail to comply with the ADA and contribute to persisting inequities in care.

MLMIC is pleased to announce the release of its latest online Risk Management CME program, Proactive Risk Management Follow-Up Program VIII. Those who complete the program can qualify for both premium credit and CME credits and may become eligible for the NYS “free” excess insurance program.

NYS Public Health Law requires that a written treatment plan be placed in the patient’s medical record when a practitioner prescribes opioids for pain management for longer than three months or past the time of normal tissue healing.

Online registration is open for MLMIC’s April 11 Risk Management Program at the Westchester Marriott Hotel (670 White Plains Road) in Tarrytown. The conference qualifies physicians for CME credit and covers current risk management issues facing all specialties.

1099-B tax forms for recipients of cash consideration from MLMIC’s acquisition by National Indemnity Company will be sent on February 25 via Computershare. The mailing will contain an explanatory insert and a 1099-B tax statement required by the IRS.

A recent study has identified that transmission of hepatitis is possible even when using sterile needles and syringes. MLMIC encourages all medical professionals to remain vigilant with use of proper technique for the administration of injectable medications.

The American Dental Association (ADA) has responded to recent media coverage of a study that had raised concerns about the safety of dental floss. Pointing out that the U.S. Food and Drug Administration has placed no restrictions on the use of dental floss, ADA says it finds “no cause for concern based on current evidence.”